Low‐Dose Olanzapine Plus Granisetron and Dexamethasone for Carboplatin‐Induced Nausea and Vomiting in Patients with Thoracic Malignancies: A Prospective Multicenter Phase II Trial

BACKGROUND: Olanzapine is an inexpensive and durable agent for the treatment of chemotherapy‐induced nausea and vomiting and is also superior to neurokinin‐1 receptor antagonists in the control of nausea. This study aimed to investigate the efficacy and safety of a low dose of 5 mg olanzapine plus g...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Sakai, Chizuru, Shimokawa, Mototsugu, Iihara, Hirotoshi, Fujita, Yukiyoshi, Ikemura, Shinnosuke, Hirose, Chiemi, Kotake, Mie, Funaguchi, Norihiko, Gomyo, Takenobu, Imai, Hisao, Hakamata, Jun, Kaito, Daizo, Minato, Koichi, Arai, Takahiro, Kawazoe, Hitoshi, Suzuki, Akio, Ohno, Yasushi, Okura, Hiroyuki
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2021
Assuntos:
Symptom Management and Supportive Care
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8176968/
https://ncbi.nlm.nih.gov/pubmed/33811782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13772
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados